Condition
MCRC clinical trials and research
As of November 12, 2026, Find a Trial lists 2 MCRC clinical trials that are recruiting, at sites in 2 countries (most in China (1), United States (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Adding pelareorep to FOLFIRI and bevacizumab for second-line RAS‑mutated, MSS metastatic colorectal cancer
This trial tests whether adding the oncolytic virus pelareorep to standard FOLFIRI plus bevacizumab helps people with RAS‑mutated, microsatellite‑stable metastatic colorectal cancer who progressed after first‑line oxaliplatin therapy.
-
Immunotherapy with Thymalfasin for Advanced Colorectal Cancer
This study is testing if adding a new drug called Thymalfasin to a standard treatment can help people with advanced colorectal cancer live longer without their disease getting worse.
Related topics
Quick answers
How many MCRC clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.